Safeguard in search for Euro distribution partner
This article was originally published in Clinica
Executive Summary
US-based Safeguard Medical Devices is looking for a partner to distribute its Disintegrator Plus home-use needle and lancet destroying device in Europe. The device, which is marketed mainly at diabetics, won FDA approval for home use in April and the company is expecting CE-Marking approval within the next couple of months. The American Diabetes Association, which has voiced concern over the dangers posed by the 3.6 billion syringes discarded in the US every year, has also given the device its stamp of approval.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.